Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)A Vaccine Trial for Low Grade Gliomas
Phase 2
Recruiting
- Conditions
- Low Grade Glioma
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- James Felker
- Target Recruit Count
- 25
- Registration Number
- NCT02358187
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides with Imiquimod
Phase 1
Recruiting
- Conditions
- Ependymoma
- Interventions
- Biological: HLA-A2 restricted synthetic tumor antigenOther: enzyme-linked immunosorbent assayOther: flow cytometryOther: immunohistochemistry staining methodOther: laboratory biomarker analysis
- First Posted Date
- 2013-02-20
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- James Felker
- Target Recruit Count
- 24
- Registration Number
- NCT01795313
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas
Phase 1
Completed
- Conditions
- Newly Diagnosed Pediatric Pontine GliomaNewly Diagnosed Pediatric High Grade GliomaRecurrent Pediatric Low Grade GliomaRecurrent Pediatric High Grade Glioma
- Interventions
- Biological: HLA-A2 restricted glioma antigen peptides vaccine
- First Posted Date
- 2010-05-25
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- James Felker
- Target Recruit Count
- 60
- Registration Number
- NCT01130077
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
News
No news found